Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting

Fig. 1

Overall survival by relevant clinical pathologic features and biomarkers of coagulation activation. a Overall survival (OS) by age at breast cancer diagnosis. The cut off was defined upon the median age at the study population level; b overall survival (OS) by T size as assessed by the pathologist on surgical specimen (pT); c overall survival by plasmatic levels of Factor VIII (FVIII). d Overall survival (OS) by plasmatic levels of D-Dimer (DD)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us